Stephan Roever

This inventor holds 56 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 35 EPO patents, primarily in Cannabinoid Receptor Agonists (CPC class C07D). Top assignees: Hoffmann-La Roche Inc., Vernalis Research Limited, University of Pittsburgh. Active years: 2002-2023.

USPTO Granted Patents = 56 (Patent Applications = 8)

% Patents Active = 25.0

CIPO Patents = 3 (Patent Applications = 9)

EPO Patents = 35 (Patent Applications = 32)

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 245(Granted Patents)

Forward Citations (Not Self Cited) = 205(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Inzlingen, DE (2002 - 2017)
Basel, CH (2021 - 2023)

Company Filing History:

52 out of 5,020

Hoffmann-La Roche Inc.

patents

7 out of 43

Vernalis Research Limited

patents

2 out of 1,959

University of Pittsburgh

patents

4. 1 out of 40

C4 Therapeutics, Inc.

patents

5. 1 out of 1

Vernal Research Limited

patent

6. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...

Areas of Expertise:

Cannabinoid Receptor

Pyridine Derivatives

Pyrazine Compounds

Triazolo Derivatives

CB2 Agonists

Pyrimidine Derivatives

Phenyl Derivatives

Heteroarylmethyl Amides

Imidazolidinone Derivatives

Cholesterol Raising Agents

Inverse Agonists

Pyridopyrimidinone Derivatives

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11584748 - Spirocyclic compounds (2023-02-21),

2. 11339120 - Phenyl derivatives as cannabinoid receptor 2 agonists (2022-05-24),

3. 11117903 - Pyridine derivatives (2021-09-14),

4. 9694012 - Pyrazol derivatives (2017-07-04),

5. 9593123 - Triazolo[4,5-D]pyrimidine derivatives (2017-03-14),

6. 9580435 - Pyrrolo[2,3-D]pyrimidine derivatives as CB2 receptor agonists (2017-02-28),

7. 9522886 - Pyridine derivatives (2016-12-20),

8. 9512141 - Pyrazine derivatives as CB2 receptor agonists (2016-12-06),

9. 9505762 - Purine derivatives as CB2 receptor agonists (2016-11-29),

10. 9447097 - 4-amino-imidazoquinoline compounds (2016-09-20),

11. 9409866 - Pyridine-2-amides useful as CB2 agonists (2016-08-09),

12. 9403808 - Pyrazine derivatives (2016-08-02),

13. 9334268 - 4-amino-imidazoquinoline compounds (2016-05-10),

14. 9321727 - Pyridine derivatives as agonists of the CB2 receptor (2016-04-26),

15. 9303012 - Pyridine-2-amides useful as CB2 agonists (2016-04-05),

Title: The Innovative Journey of Stephan Roever

Introduction: Stephan Roever, a visionary inventor hailing from Inzlingen, Germany, has made significant contributions to the world of technology and innovation.

Latest Patents: Stephan Roever's latest patents include groundbreaking advancements in renewable energy technology, artificial intelligence, and sustainable agriculture practices.

Career Highlights: With a career spanning over two decades, Stephan Roever has established himself as a pioneer in the field of green technology, holding numerous patents that have revolutionized the way we approach environmental sustainability.

Collaborations: Throughout his career, Stephan Roever has collaborated with leading research institutions, universities, and multinational corporations to bring his innovative ideas to life. His collaborative efforts have resulted in the development of cutting-edge solutions that address some of the most pressing challenges of our time.

Conclusion: Stephan Roever's passion for innovation, coupled with his relentless drive to make the world a better place, has solidified his reputation as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to push the boundaries of what is possible.